Cellectar Biosciences Inc (CLRB)

Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Research and Development	7.04% 7.3779	7.9365	7.3125	6.3084	6.6541
Costs And Expenses	4.35% 12.00	12.55	9.4135	8.294	8.7053
Operating Income/Loss	4.35% -12.00	-12.55	-9.4135	-8.294	-8.7053
Nonoperating Income/Loss	290.11% -9.5802	5.0392	-4.3189	0.0728	0.124
Income/Loss From Continuing Operations Before Tax	3.19% -12.00	-11.63	-9.4135	-8.2212	-8.5813
Income/Loss From Continuing Operations After Tax	189.74% -21.58	-7.4487	-13.73	-8.2212	-8.5813
Net Income/Loss	189.74% -21.58	-7.4487	-13.73	-8.2212	-8.5813
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,008% 29.35	0.9443	11.31	11.26	11.26
Diluted Average Shares	3,008% 29.35	0.9443	11.31	11.26	11.26
Basic Earnings Per Share	85.00% -0.74	-0.40	-1.21	-0.73	-0.76
Diluted Earnings Per Share	85.00% -0.74	-0.40	-1.21	-0.73	-0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-